Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

Link Between Antibiotics and Biofilms

Researchers from USC and the Oak Crest Institute of Science have discovered the link between antibiotics and bacterial biofilm formation leading to ...read more

Anthrax Incident Points to Safety Issues

The Centers for Disease Control and Prevention (CDC) released a report today that reviews the early June incident that involved the ...read more

Tetanus Infection

The CDC offers information on tetanus infection caused by Clostridium tetani. ...read more

Healthcare Reform

Infection prevention's role in quality improvement initiatives is becoming more of an imperative within the overall efforts by healthcare ...read more

Latest Headlines

Anadys Pharmaceuticals Reports Hepatitis C Viral Load Reduction in Completed Phase IB Clinical Trial of Isatoribine

SAN DIEGO -- Anadys Pharmaceuticals, Inc., a biopharmaceutical company committed to the discovery, development and commercialization of novel medicines to treat chronic viral hepatitis and bacterial infections, reported new data from a recently completed multi-component ...More
November 3, 2004 Posted in News
Successful Phase I Clinical Trial of spi-VECTM Oral Hepatitis B Vaccine Paves the Way for Phase II Efficacy Trial

WOKINGHAM, England -- Microscience is announcing further significant results from a Phase I clinical study of its spi-VECTM oral immunotherapeutic vaccine designed for the treatment of subjects chronically infected with the hepatitis B virus (“HBV”). The trial met its ...More
November 3, 2004 Posted in News
Fast-Growing Market for RNAi Products Shows No Signs of Slowing

ARLINGTON, Va. -- The promise of RNA interference (RNAi) therapeutics to combat human illnesses such as Huntington's disease, Lou Gehrig's disease and hepatitis C has vastly increased scientific interest in the field. In fact, according to a recent survey, 65 percent of ...More
November 3, 2004 Posted in News
Mail-Order Drugs Exposed To Extreme Heat

Seattle, WA – Mail-order prescriptions exposed to excessive environmental heat, such as temperatures found in mailboxes and car interiors, may become significantly less effective for patients. In a new study presented at CHEST 2004, the 70th annual international scientific ...More
November 3, 2004 Posted in News
Red Wine Mist? Resveratrol Shows Potential Effects Against COPD, Asthma, Arthritis

BETHESDA, Md. – Homing in on mechanisms for the reported effectiveness of resveratrol, which is found in red wine, researchers at Imperial College London, England, confirmed its broad anti-inflammatory action, and found potential for applications in chronic obstructive ...More
November 3, 2004 Posted in News
Study Shows Differences In Natural Immunity In Cloned Pigs

Studies by scientists with the U.S. Department of Agriculture and the University of Missouri indicate that the natural immune system of young cloned pigs does not appear to fight diseases as effectively as the immune system of non-cloned pigs. Animal physiologist Jeff ...More
November 3, 2004 Posted in News
Mumps Cases Among Young Adults Continue to Increase

Following a continued increase in cases of mumps among teenagers and young adults in recent years, the Health Protection Agency’s local teams have been working with schools and universities where outbreaks have taken place, to ensure that students are vaccinated. During the ...More
November 3, 2004 Posted in News
FDA Completes Review of Reprocessed Single Use Devices

The Food and Drug Administration (FDA) announced that it has completed its review of supplemental validation data submitted by firms that reprocess medical devices originally intended for single use only (SUDs). The Medical Device User Fee and Modernization Act of 2002 ...More
November 3, 2004 Posted in News
Stretching the Supply of Flu Vaccine: Solution Offered

New research demonstrates a possible way to more than double the available supply of influenza vaccine for adults between the ages of 18 and 60, according to a study led by Saint Louis University’s Center for Vaccine Development and appearing this week in the New England ...More
November 3, 2004 Posted in News
InterMune Announces Presentation of Clinical Data on Infergen Plus Ribavirin in Difficult to Treat HCV Patients

BOSTON -- InterMune, Inc. announced the presentation of clinical findings from three separate investigator-initiated studies of the use of Infergen® (interferon alfacon-1) in combination with ribavirin for the treatment of Hepatitis C (HCV) patients. The findings were ...More
November 3, 2004 Posted in News